<DOC>
	<DOCNO>NCT01346358</DOCNO>
	<brief_summary>A dose escalation study establish safety profile characterize pharmacokinetic profile IMC-CS4 treatment subject advance solid tumor refractory standard therapy standard therapy available .</brief_summary>
	<brief_title>A Study IMC-CS4 Subjects With Advanced Solid Tumors</brief_title>
	<detailed_description />
	<criteria>Subject histologic cytologic confirmation advance solid tumor refractory standard therapy standard therapy available Subject measurable nonmeasurable disease accord Response Evaluation Criteria Solid Tumors ( RECIST ) Version 1.1 Subject resolution grade â‰¤1 NCICTCAE ( Common Toxicity Criteria Adverse Effects ) Version 4.03 clinically significant toxic effect prior treatment Subject Eastern Cooperative Oncology Group ( ECOG ) performance status 02 Subject adequate hematologic , hepatic , renal , coagulation function Subject life expectancy great 3 month Subject agrees use adequate contraception study period 12 week last dose study therapy Subject must undergo mandatory biopsy , include one pretreatment one post treatment tumor biopsy procedure Subject experience acute pathologic fracture spinal cord compression within 28 day prior first dose study therapy Subject know hypersensitivity monoclonal antibody agent similar biologic composition IMCCS4 . Subject receive treatment monoclonal antibody within 4 week prior first dose study therapy Subject undergone major surgical procedure , open biopsy , radiofrequency ablation experience significant injury within 28 day prior enrollment Subject concurrent active malignancy adequately treat nonmelanomatous skin cancer situ neoplasm Subject ongoing active infection , symptomatic congestive heart failure , uncontrolled hypertension , active bleed serious uncontrolled medical disorder Subject know suspect primary brain leptomeningeal metastasis Subject leukemia lymphoma Subject know active tuberculosis , leishmaniasis , listeriosis Subjects know history , clinical laboratory evidence liver disease Subject know active hepatitis B C infection , Human immunodeficiency virus ( HIV ) infection acquire immunodeficiency syndrome ( AIDS ) Subject female , pregnant breastfeeding Subject receive organ transplant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
	<keyword>Advanced Solid Tumors</keyword>
</DOC>